SELLING SECURITYHOLDER
The “Selling Securityholder” table, along with the applicable footnotes, as previously presented on page 15 of the prospectus, is hereby amended and supplemented by this Prospectus Supplement.
On October 27, 2021, Reliance assigned all of its rights in the Warrants to Goldman Sachs & Co. LLC along with, pursuant to the Reliance Registration Rights Agreement (as previously defined in the prospectus), its right to cause us to register the resale of the Warrants and the Warrant Shares. The information set forth in the table below has been updated solely to add Goldman Sachs & Co. LLC as a selling securityholder as a result of the foregoing assignment.
The table below sets forth information as of May 26, 2022, with respect to the selling securityholder, the number of Warrants and shares of common stock owned by the selling securityholder prior to this offering, the percentage of common stock owned by the selling securityholder prior to this offering, the number of Warrants and Warrant Shares being offered pursuant to the prospectus, the number of Warrants and shares of our common stock owned by the selling securityholder upon completion of this offering, assuming all such securities are sold, and the percentage of common stock owned by the selling securityholder after this offering, assuming all such securities are sold.
In the table below, the number of shares of common stock that may be offered pursuant to the prospectus is the number of shares of common stock issuable pursuant to the Warrants without regard to any limitations on exercises. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the prospectus also covers any additional shares of our common stock that may become issuable in connection with shares of common stock by reason of a stock dividend, stock split or other similar transaction effected without our receiving any cash or other value, which results in an increase in the number of shares of our common stock outstanding.
As used in this Prospectus Supplement, the term “selling securityholder” includes the selling securityholder listed below, and any donees, pledgees, transferees or other successors in interest selling the Warrants or Warrant Shares received after the date of this Prospectus Supplement from the selling securityholder. The number of shares in the column “Beneficially Owned Prior to Offering—Warrants—Number” represents all of the Warrant Shares that the selling securityholder may offer under the prospectus without regard to any limitations on exercises. The selling securityholder may sell some, all or none of its Warrants or Warrant Shares. The selling securityholder may sell or transfer all or a portion of its Warrants or Warrant Shares pursuant to an available exemption from the registration requirements of the Securities Act. We do not know how long the selling securityholder will hold the Warrants or Warrant Shares before selling them, and we currently have no agreements, arrangements or other understandings with the selling securityholder regarding the sale of any of the Securities.
To our knowledge, the person named in the table has sole voting and investment power with respect to all of the securities shown as beneficially owned by such person. The number of securities shown represents the number of securities the person “beneficially owns,” as determined by the rules of the SEC. The SEC has defined “beneficial” ownership of a security to mean the possession, directly or indirectly, of voting power and/or investment power. A securityholder is also deemed to be, as of any date, the beneficial owner of all securities that such security holder has the right to acquire within 60 days after that date through (1) the exercise of any option, warrant or right, (2) the conversion of a security, (3) the power to revoke a trust, discretionary account or similar arrangement or (4) the automatic termination of a trust, discretionary account or similar arrangement.
Under the terms of the Warrants, the selling securityholder may not exercise such securities to the extent such exercise would cause such selling securityholder, together with its affiliates and attribution parties, to beneficially own a number of shares of our common stock that would exceed 4.99% of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of our common stock issuable upon exercise of the warrants which have not been exercised. This beneficial ownership limitation may be adjusted up or down, subject to providing advance notice to us; provided that any increases in beneficial ownership limitations only take effect upon 61 days advance notice.
The percentages reflect beneficial ownership immediately prior to and immediately after the completion of this offering as determined in accordance with Rule 13d-3 under the Exchange Act and are based on 77,333,290 shares of our common stock outstanding as of May 26, 2022.